Monica Rose McLemore

Faculty

Monica McLemore headshot

Monica Rose McLemore

PhD RN MPH FADLN

Professor

1 212 998 5319

433 FIRST AVENUE
NEW YORK, NY 10010
United States

Monica Rose McLemore's additional information

Prof. Monica R. McLemore is a Visiting Professor at NYU Meyers and is a noted scholar of antiracist birth equity research and national expert on reproductive health, rights, and justice.

Prior to joining NYU Meyers, McLemore was a tenured professor, holding the Endowed Chair for Health Promotion and is Director of the Manning-Price Spratlan Center for Anti-Racism and Equity in Nursing at the University of Washington (UW). Before UW, she was a tenured associate professor at the University of California, San Francisco (UCSF) School of Nursing, and held the Thelma Shobe Endowed Chair in Ethics and Spirituality.

Over a career spanning more than three decades, McLemore has distinguished herself as a scientist and clinical nurse whose work advancing understanding of reproductive health and justice has been cited in varied ways across many platforms, including six amicus briefs to the U.S. Supreme Court and publications ranging from Politico to Scientific American. She made a voice appearance on the Peabody Award-winning HBO series “Random Acts of Flyness”, and is editor-in-chief of the journal, Health Equity

McLemore also has an impressive record of mentoring diverse scholars and students, and in expanding the use of community-engaged research methods, in particular involving underrepresented groups in the research process.

Among her many awards, McLemore was recognized as the Society of Family Planning’s Mentor of the Year and honored with the American Public Health Association's Outstanding Leadership and Advocacy Award for her work on maternal child health.

PhD, University of California
MPH, San Francisco State University
Minority Training Program in Cancer Control Research
BSN, The College Of New Jersey
Research Fellow, NINR Summer Genetics Institute
Anti-Racism and Equity
Health Equity
Health Policy
Reproductive Health
Society of Family Planning
American College of Obstetrics and Gynecology
Washington State Nurses Association
Academy Health
Abortion Access Front
Health Equity Journal

Faculty Honors Awards

Fellow, New York Academy of Medicine (2025)
Trailblazer Award, National Black Nurses Association (2025)
Harriet Cook Carter Lecture, Duke University (2025)
Inaugural Recipient of the SFGH Catalyst Award, Zuckerberg San Francisco General Hospital First Annual Nursing Research Symposium (2025)
National Academy of Sciences Kavli Fellowship, Reproductive Justice Unit (2025)
Fellow, Academy of Diverse Leaders in Nursing (2024)
2024 STATUS List, Stat News (2024)
McCausland Visiting Scholars, University of South Carolina (2024)
Excellence in Promoting Diversity Through Teaching Award, University of Washington School of Nursing (2024)
Researcher of the Year, Washington State Nurses Association (2023)
Legacy Award, Marcus Foster Education Institute’s 100 for the 100th Legacy Award recipients (2023)
Nurse Influencer on Social Media, Berxi (2023)
Mentor of the Year, Society of Family Planning (2022)
Alumni of the Year, The College of New Jersey School of Nursing (2022)
Maternal Child Health Section Outstanding Leadership and Advocacy Award, American Public Health Association (2021)
Nurse Influencer on Social Media, Berxi (2021)
Nursing Mutual Aid #2020: Global Hero Award, The Gay and Lesbian Medical Association (2020)
Distinguished Leadership Award, The College of New Jersey (Alumni) (2020)
The Audacious Award, Alumni Association UCSF Foundation (2020)
Fellow, American Academy of Nursing (2019)
Excellence in Leadership Award, AWHONN (2019)
Thomas N. Burbridge Award, UCSF Chancellor's University Service Award (2019)
Person of the Year, Abortion Care Network (2018)
Association for Reproductive Health Professionals, Amazing Women in Reproductive Health (2017)
The Association for Wholistic Maternal and Newborn Health, Agent - Provocateur of the Year Award (2017)
Margretta Madden Styles Award, Sigma Theta Tau International (2017)
Excellence in Teaching Award, American College of Nurse Midwives (2015)
Speaking Race to Power Fellow, CoreAlign (2015)
Breakthrough Leaders in Nursing Award, Robert Wood Johnson Foundation (2015)
UCSF Alpha Eta Leadership Hall of Fame, Sigma Theta Tau International (2014)
Doctoral Scholarship in Nursing, American Cancer Society (2007)
National Institute for General Medical Sciences Fellowship, UCSF (2003)
Cota Robles Regents Fellowship, UCSF (2002)
Outstanding Service Award, The Resident Staff of the Department of Gynecology and Obstetrics, Stanford University School of Medicine (2000)
New Jersey Garden State Scholarship Program (1998)

Publications

The role of the data safety monitoring board: why was the Avastin phase III clinical trial stopped?

McLemore, M. R., & McLemore, M. R. (2006). In Clinical journal of oncology nursing (Vols. 10, Issues 2, pp. 153-4).
Abstract
Abstract
In early February 2006, Genentech Inc. issued a joint press release with Roche Holding Corporation explaining that their phase III early-stage colon cancer trial of Avastin (bevacizumab, Genentech Inc., South San Francisco, CA) would be stopped after the deaths of four patients. This announcement was the result of preliminary review of the data by the Data Safety Monitoring Board (DSMB) that was formed to monitor the study. What is the DSMB? What criteria does it use to determine whether a study should be stopped early? The purpose of this article is to (a) explain the role of the DSMB, (b) give an overview of the Avastin Adjuvant (AVANT) study, and (c) provide information and resources about clinical trials for practicing RNs in oncology.

Workplace aggression: beginning a dialogue

McLemore, M. R., & McLemore, M. R. (2006). In Clinical journal of oncology nursing (Vols. 10, Issues 4, pp. 455-6).
Abstract
Abstract
The June 2005 Clinical Journal of Oncology Nursing editorial titled "Communication: Whose Problem Is It?" (Griffin-Sobel, 2005) was written to begin a dialogue about a phenomenon frequently experienced yet rarely discussed: workplace aggression, also known as disruptive behavior. Prompted by a groundbreaking study published in the American Journal of Nursing by Rosenstein and O'Daniel (2005), the editorial challenged oncology nurses to begin to fix problems of communication. After reflecting on both of the articles and considering my own experience as a nurse manager, clinician, and scholar, I decided to explore the topic as it relates to nurse-to-nurse workplace aggression. The following is a summary of interviews with nurse managers, nurse practitioners, and nurse scientists about root causes and effective strategies to manage these sometimes complicated situations. This article is meant to continue the dialogue about the very sensitive issue. Confidentiality has been maintained, and I welcome your comments.

Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer

McLemore, M. R., McLemore, M. R., & Aouizerat, B. (2005). In Biological research for nursing (Vols. 6, Issues 4, pp. 262-7).
Abstract
Abstract
More than 24,000 women in the United States are diagnosed with ovarian cancer every year, and half of these women die from their disease. Stage 1 ovarian cancer is curable in 95% of cases; however, due to inadequate screening tools and lack of symptoms in early disease, ovarian cancer is generally at Stage 3 or 4 when finally diagnosed. CA125 is a tumor antigen used to monitor the progression and regression of epithelial ovarian cancer. When its levels are elevated postsurgery (hysterectomy/salpingo-oophorectomy with or without peritoneal washings and lymph node biopsy) and postchemotherapy, it is suggestive of recurrent disease. Due to its similarly elevated levels in some nonmalignant conditions, however, it is not specific enough to be used for population screening. The CA125 molecule is considered a very large glycoprotein because of its molecular weight, and it has three domains: the carboxy terminal domain, the extracellular domain, and the amino terminal domain. MUC16 is the gene that encodes the peptide moiety of the CA125 molecule. MUC16 domains provide novel opportunities to develop new assays and refine current tools to improve the sensitivity and specificity of CA125 for population-based screening guidelines.

Alspaugh A, Suárez-Baquero DFM, Mehra R, Lanshaw, N, Joseph J, Combs M, Spiller K, McLemore MR, Franck LS. (2023). Patients want to see people that look like them”: Aspiring midwives of color as resistance to racism through concordant care in the United States. SSM - Qualitative Health Research, Volume 3, 100226.

McLemore, M. R. (100226th eds., Vols. 3).
Abstract
Abstract
~

Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort

McLemore, M. R., Radzik, A. M., Amezcua, L., Anderson, A., Gilmore, S., Ahmad, S., Brandstadter, R., Fabian, M. T., Graham, E. L., Hodgkinson, S., Horton, L., Jacobs, D. A., Sand, I. B., Kohli, A., Levine, L., Mclemore, M., Okai, A. F., Patel, J., Poole, S., … Bove, R. In NEUROLOGY.
Abstract
Abstract
~